Financial Statement January 1 to December 31 2022
Faron Pharmaceuticals Oy Faron’s Financial Statement Release January 1 to December 31, 2022 Financial statement release March 3, 2023 at 09:00 AM (EET) / 07:00 AM (GMT) / 03:00 AM (EDT) TURKU, FINLAND / BOSTON, MA – Faron Pharmaceuticals Oy (“Company”, AIM: FARN, First North: FARON) together with its subsidiaries (“Faron”), a clinical stage biopharmaceutical group focused on building the future of immunotherapy by harnessing the power of the immune system to tackle cancer and inflammation, today announced audited full-year financial results for January 1 to December 31,